MDXHEALTH

MDxHealth, an Irvine, California-based cancer diagnostics laboratory, engaged Media Directions Creative Group to help build recognition of the company’s newly developed brand identity and to support the launch and market adoption of ConfirmMDx for Prostate Cancer. A laboratory developed test (LDT), ConfirmMDx for Prostate Cancer measures a patient’s prostate biopsy tissue for the methylation of certain genes. The molecular test, which has very high specificity and sensitivity and notably a 98% negative predictive value, can reduce unnecessary and painful repeat biopsies. The well-respected MDxHealth now has a number of other cancer tests in the pipeline. Media Directions has enjoyed a longstanding relationship with the company’s leadership.  www.mdxhealth.com